HER2与乳腺癌靶向治疗的研究进展附视频

被引:6
作者
姜扩 [1 ]
王立锋 [2 ]
裘秀春 [1 ]
机构
[1] 第四军医大学唐都医院骨肿瘤研究所
[2] 第四军医大学生物化学和分子生物学教研室
关键词
HER2分子; 乳腺癌; 靶向治疗;
D O I
暂无
中图分类号
R737.9 [乳腺肿瘤];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:425 / 427+432 +432
页数:4
相关论文
共 8 条
[1]
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies[J] Jaclyn A. Freudenberg;Qiang Wang;Makoto Katsumata;Jeffrey Drebin;Izumi Nagatomo;Mark I. Greene Experimental and Molecular Pathology 2009,
[2]
Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo[J] Manran Liu;Xiaoming Ju;Nicole E. Willmarth;Mathew C. Casimiro;John Ojeifo;Toshiyuki Sakamaki;Sanjay Katiyar;Xuanmao Jiao;Vladimir M. Popov;Zuoren Yu;Kongming Wu;David Joyce;Chenguang Wang;Richard G. Pestell The American Journal of Pathology 2009,
[3]
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes; CA9 and VEGF ; in human cancer cell lines[J] Norazizah Shafee;Stefan Kaluz;Ning Ru;Eric J. Stanbridge Cancer Letters 2009,
[4]
EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy[J] Milanezi;Carvalho;Schmitt Expert Review of Molecular Diagnostics 2008,
[5]
Unraveling the Biologic and Clinical Complexities of HER2[J] John W. Park;Richard M. Neve;Janos Szollosi;Christopher C. Benz Clinical Breast Cancer 2008,
[6]
Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era[J] Filippo Montemurro;Stefania Redana;Giuseppe Viale;Giuseppina Sanna;Michela Donadio;Giorgio Valabrega;Barbara del Curto;Alberto Bottini;Gerardo Botti;Angelo Paolo dei Tos;Maria Elena Jacomuzzi;Maurizio Di Bonito;Saverio Danese;Matteo Clavarezza;Janina Kulka;Silvana Di Palma;Antonio Durando;Anna Sapino;Massimo Aglietta Clinical Bre
[7]
The E75 HER2/ neu peptide vaccine[J] Elizabeth A. Mittendorf;Jarrod P. Holmes;Sathibalan Ponniah;George E. Peoples Cancer Immunology; Immunotherapy 2008,
[8]
Investigating the Combination of Trastuzumab and HER2/neu Peptide Vaccines for the Treatment of Breast Cancer[J] Elizabeth A. Mittendorf;Catherine E. Storrer;Craig D. Shriver;Sathibalan Ponniah;George E. Peoples Annals of Surgical Oncology 2006,